Evidence method
Level · gp.fundamentals.debt_to_revenue
267.76% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ELAN · Jun 30, 2026
Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001739104-26-000043General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.41% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.25% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
10.23% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
129.31% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
58.33% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.73% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.46% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 272.50%
- Current
- 267.76%
- Delta
- -4.74%
- Previous
- 3.72%
- Current
- 2.41%
- Delta
- -1.31%
- Previous
- 0.95%
- Current
- 20.25%
- Delta
- 19.30%
- Previous
- 14.92%
- Current
- 10.23%
- Delta
- -4.69%
- Previous
- 125.24%
- Current
- 129.31%
- Delta
- 4.08%
- Previous
- 57.26%
- Current
- 58.33%
- Delta
- 1.08%
- Previous
- 7.08%
- Current
- 6.73%
- Delta
- -0.35%
- Previous
- 1.53%
- Current
- 1.46%
- Delta
- -0.07%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 75%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 74%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 74%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 73%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 69%
- Compared
- 8 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Analogous To · ELAN state analogue 3 →Analogous To · ELAN state analogue 1 →Analogous To · ELAN state analogue 4 →Compared To · Pharmaceutical Preparations peers →Analogous To · ELAN state analogue 2 →Analogous To · ELAN state analogue 5 →Derived From · ELAN Company Quality Vector →Has State · Elanco Animal Health Inc →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ELAN CAPEX_INTENSITY_DECREASED →Transitioned To · ELAN CASH_GENERATION_INCREASED →Transitioned To · ELAN GROWTH_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.